- Journal of Experimental and Clinical Medicine
- Vol: 39 Issue: 2
- Abciximab-induced thrombocytopenia: correct management
Abciximab-induced thrombocytopenia: correct management
Authors : Engin KELKİTLİ, Aslı ODABAŞI GİDEN, Derya DENİZ KÜREKÇİ, Mehmet TURGUT
Pages : 581-583
View : 11 | Download : 1
Publication Date : 2022-03-18
Article Type : Other
Abstract :Thrombocytopenia is a possible side effect of routinely administered medical agents. Abciximab is one of the three potent intravenous glycoprotein IIb/IIIa receptor inhibitors (along with eptifibatide and tirofiban) that have shown significant positive outcomes when used in patients with intracoronary thrombus. The use of abciximab was associated with the risk of thrombocytopenia. In this case, the development of thrombocytopenia and treatment management were reported after the use of abciximab.Keywords : Abciximab, glycoprotein IIb/IIIa receptor inhibitors, side effect, thrombocytopenia